Prana Biotechnology Limited Stock Nasdaq
Equities
US7397272045
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 2.58M | Sales 2025 * | 3.77M | Capitalization | 17.75M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -11M | EV / Sales 2024 * | 5.67 x |
Net cash position 2024 * | 3.11M | Net cash position 2025 * | 6.62M | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.93% |
Latest transcript on Prana Biotechnology Limited
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 17-04-30 |
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 14-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Peter Marks
BRD | Director/Board Member | 68 | 05-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 11-08-07 |
1st Jan change | Capi. | |
---|---|---|
+23.72% | 45.01B | |
+47.19% | 40.96B | |
-5.39% | 38.62B | |
+37.18% | 32.6B | |
-7.79% | 27.49B | |
+18.21% | 27.17B | |
+48.06% | 14.61B | |
+40.59% | 12.95B | |
-1.05% | 11.36B |